MERRIMACK PHARMACEUTICALS INC Long-Term Debt, Maturity, Year Three
MERRIMACK PHARMACEUTICALS INC had Long-Term Debt, Maturity, Year Three of $6.61 million as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2019-05-10
- 2019-03-31: Long-Term Debt, Maturity, Year Three $6.61M.
- 2018-12-31: Long-Term Debt, Maturity, Year Three $6.60M.
- 2018-09-30: Long-Term Debt, Maturity, Year Three $8.40M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2019-03-31 | $6.61M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $6.60M 10-K · filed 2019-03-06 |
| 2018-09-30 | $8.40M 10-Q · filed 2018-11-07 |